Researchers develop nanoparticle treatment approach for optimized pancreatic cancer therapy

Pancreatic cancer is one of the deadliest types of cancers in humans. It is the fourth leading cause of cancer-related deaths in the western world. The early stages of the disease often progress without symptoms, so diagnosis is usually very late. Another problem is advanced tumors—and their metastases—can no longer be completely removed. Chemotherapies, in turn, attack not only the tumor cells but also healthy cells throughout the body.